CELEBRATE: Prehospital Platelet Inhibitor Zalunfiban Hits Mark in STEMI

Can ICDs improve survival in post-MI patients with mildly impaired LVEF? @mmamas1973.bsky.social and Derek Exner discuss this topic during the recent #ESCCongress2025. www.tctmd.com/videos/beyon...

Patients hospitalized for CVD conditions may misunderstand potential risks communicated by clinicians. “This disconnect can have serious implications, not only for patient satisfaction but also for adherence to treatment and overall outcomes," said Juan Górriz-Magaña. www.tctmd.com/news/disconn...

Don’t miss your chance to apply for the Cardiovascular Innovation Fellowship at Edwards Lifesciences. Join a program where people power innovation to transform care for patients with structural heart disease. bit.ly/4mhu2gI #Sponsored #CardioFellow #Cardiology

At #ESCCongress2025, @mmamas1973.bsky.social and Raffaele Piccolo talk about the PARTHENOPE trial that tested a new polymer-free drug-eluting stent. www.tctmd.com/videos/beyon...

Good LDL Control When PCSK9 Inhibitors Given In-Hospital After Interventions

AI Model Saves Time, Increases Accuracy of Echo Measurements

Clinicians who rely on AI to make major medical decisions were seen as less skilled and competent by their peers compared to those who didn't use it at all. Even if used for verification purposes, perception of skill improved slightly but not by much. www.tctmd.com/news/doctors...

Transthyretin cardiac amyloidosis is the leading cause of HF in older Black patients, particularly for men, and screening with nuclear imaging should be more frequent for this population, based on findings from the SCAN-MP study. www.tctmd.com/news/transth...

The proposed reimbursement cuts for amyloid imaging are being fought by @asnc.bsky.social, which argued that the cuts would hinder the ability of physicians to treat patients with newly approved drugs for transthyretin amyloid cardiomyopathy. More here: www.tctmd.com/news/asnc-fi...

In this Beyond the Data, @mmamas1973.bsky.social, Giuseppe Tarantini, and Pedro Lemos discuss two new trials that were presented at #ESCCongress2025 which looked at anticoagulation strategies in post-ACS patients. www.tctmd.com/videos/beyon...

European Experts Provide Advice on Managing CV Effects of COVID-19

The @worldheart.org is pushing for wider adoption of polypills for CVD prevention worldwide. Evidence on its benefits continue to be solid, but actual usage remains low, according to Enrico Ferro. www.tctmd.com/news/whf-str...

This just in. 📢 The list of scientific abstracts featured at #TCT2025 is now live in the Program Guide! www.tctconference.com/program-guid... Get a glimpse of the groundbreaking original research shaping #interventionalcardiology & claim your spot today! www.tctconference.com/register #CardioSky

✨ Game-changing science. Global impact. #TCT2025 is your front-row seat to the latest breakthroughs and groundbreaking studies. Experience it live in San Francisco! www.tctconference.com/register #CardioSky

Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s

AI Tool Supports Mammograms as Method to Screen Women for CV Risk

Half of Patients Stop Semaglutide for Weight Loss by 1 Year

The second annual RISE conference at #ESCCongress2025, organized by @womenasone.bsky.social, highlighted the need to continue elevating women pursuing careers in medicine and clearing professional barriers from sexism to lack of equitable care for female patients. www.tctmd.com/news/lift-yo...

‘Buzz and Discussion’ Driving Return to In-Person Cardiology Meetings

#TCT2025 gives you front-row access to cutting-edge cardiac interventions! Witness master operators in action from cath labs around the world with live discussion and real-time decision-making.💡🌏 Explore the live case sites now & secure your spot now!🔗 www.tctconference.com/live-cases #CardioSky

Nonatherosclerotic Causes of MI Common in Younger Patients

In this episode of Talking Points, C. Michael Gibson and Sanjit Jolly discuss the OASIS 9 trial and if long-term colchicine benefits patients after acute MI. Listen now: www.tctmd.com/audio/clear-...

The CLEAR SYNERGY (OASIS 9) Trial

Guidelines for the management of dyslipidemia have been updated by @escardio.bsky.social and the EAS. The updates emphasize early LDL-lowering for select high-risk patients as well as recommendations for new drugs, statins in HIV, and early combo therapy. www.tctmd.com/news/esceas-...

Medline Recalls Valve Pack Kits With Expired Cannulas

Disconnect Exists Between What Patients Hear vs What Clinicians Try to Say

What's the link between inflammation and CVD? Caitlin E. Cox, Jean-Claude Tardif, and Charalambos Antoniades discuss this and more at #ESCCongress2025 in the latest On Record. www.tctmd.com/videos/on-re...

Thank you @tctmd.bsky.social and Caitlin Cox for highlighting RISE @ ESC Congress 2025. True change in cardiology requires mentorship, sponsorship, and community - actions that lift others as we rise. Read the article: www.tctmd.com/news/lift-yo... #LetsRISE2025 #ESCCongress #WCCardio #CardioSky

Guidelines for pregnant women with CVD have been updated by @escardio.bsky.social to emphasize personalized pregnancy-related risk assessments and shared decision-making between women and their physicians. Read more here: www.tctmd.com/news/esc-gui...

Doctors Skeptical of Their Peers Who Use Generative AI

Stopping OAC improves outcomes for patients with no atrial arrhythmia recurrences for at least a year after catheter ablation for AF. They're less likely to have a stroke, systemic embolism, or major bleeding than those who continue OAC, based on the ALONE-AF trial. www.tctmd.com/news/alone-a...

✨ Discover the future of #heartfailure treatment at #TCT2025! This is your opportunity to connect with innovators and dive into the latest data and devices shaping the field. Explore the Heart Failure Track: www.tctconference.com/program-guid... #CardioSky #MedSky

Using a noninvasive ECG patch modestly increases the detection of AF and treatment with anticoagulant therapy among patients at moderate-to-high risk for stroke, based on results from the AMALFI trial presented at #ESCCongress2025. www.tctmd.com/news/amalfi-...

More questions are raised over the safety of paclitaxel-coated devices in PAD, according to the SWEDEPAD 1 and 2 national registry trials presented at #ESCCongress2025. Read the full story here: www.tctmd.com/news/renewed...

Transthyretin Cardiac Amyloidosis a Common Cause of HF in Older Black Patients

In Beyond the Data, @mmamas1973.bsky.social and Robert Giugliano talk about the data on starting an SGLT2 inhibitor in patients hospitalized with acute heart failure during #ESCCongress2025. www.tctmd.com/videos/beyon...

Adding ticagrelor to aspirin for a year doesn't lower the risk of adverse events in ACS patients who have CABG surgery, according to the TACSI trial. Another trial, TOP-CABG, suggested starting with dual ticagrelor and aspirin for 3 months before using aspirin alone. www.tctmd.com/news/dapts-r...

ASNC Fighting Back Against Proposed Reimbursement Cuts for Amyloid Imaging

Is biologic inflammation predictive of CVD? At #ESCCongress2025, Caitlin E. Cox and Paul Ridker discuss the research behind the inflammatory hypothesis and its implications for clinical practice. www.tctmd.com/videos/on-re...

The latest Beyond the Data has @mmamas1973.bsky.social, Dan Atar, and Borja Ibáñez discussing data from the REBOOT-CNIC and BETAMI-DANBLOCK trials at #ESCCongress2025. Watch the full video now: www.tctmd.com/videos/beyon...

Lift as You Rise: Women in Cardiology Meet in Madrid to Talk Change

HVD occurs in at least 6% of patients a year after undergoing TAVI and is more frequent in those who receive smaller valve sizes and valve-in-valve procedures, according to 10 years of retrospective data from a single health system. www.tctmd.com/news/early-t...

TRILUMINATE: Late Clinical Outcomes

On the latest Rox Heart Radio, Roxana Mehran talks with Daniel Jones about the new US hypertension guidelines. www.tctmd.com/audio/2025-u...

ESC/EAS Stress Early LDL-Lowering in Select High-risk Patients

The 2025 US Hypertension Guidelines

The ESC/EACTS have released new valvular heart disease guidelines at #ESCCongress2025, which lower the age cutoff to recommend TAVI over SAVR and more strongly emphasize patient education, according to ESC chairperson Fabien Praz and EACTS chairperson Michael Borger. www.tctmd.com/news/esceact...

WHF Stresses the Importance of Polypills in Global Fight Against CVD

⏳ Only hours left to save on #TCT2025 registration! Rates increase September 10 at 12:00 AM EDT. Unlock innovation, inspiration, and connection at the world’s premier forum for #interventionalcardiology. 🚨 Register now to lock in your savings! www.tctconference.com/register #CardioSky